Compremium recently won FDA Breakthrough Device designation for its noninvasive Quantis CVP (central venous pressure) ...

In this episode of From Bench to Bedside and Beyond, Dr. Yaw Nyame and patient Dave Lucas discuss the robotic surgical ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

The case description for a Case Records of the Massachusetts General Hospital appears below. A 16-year-old girl was admitted to the hospital because of abdominal pain, nausea, and vomiting. Abdominal ...

Cava delivered better-than-expected revenue in its fourth-quarter report. Comparable sales were essentially flat. The company has a promising growth path in front of it. However, the last year has ...

CAVA remains under pressure, with sluggish same-restaurant sales and eroding margins prompting a reiterated sell rating. Top-line growth is driven almost entirely by aggressive new store openings, not ...

Cava Group’s CAVA-2.43%decrease; red down pointing triangle fourth-quarter sales rose on higher prices and better-than-expected performance at new restaurants. However, foot traffic fell at existing ...

CAVA surpassed $1 billion in revenue for the first time in fiscal 2025, proving how much the brand stands apart from peers during a challenging macroeconomic environment. The 2025 restaurant class—a ...

Cava’s same-store sales in Q4 2025 grew by 0.5%, but traffic in the quarter was down roughly 1%, CFO Tricia Tolivar told Restaurant Dive in an interview. Tolivar emphasized the brand’s performance on ...

Cava Group (NYSE:CAVA) is gearing up to announce its quarterly earnings on Tuesday, 2026-02-24. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...